No Effect of the 1α,25-Dihydroxyvitamin D(3) on β-Cell Residual Function and Insulin Requirement in Adults With New-Onset Type 1 Diabetes

por Walter, Markus, Kaupper, Thomas, Adler, Kerstin, Foersch, Johannes, Bonifacio, Ezio, Ziegler, Anette-G.
Publicado 2010

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage

por Wilke, Thomas, Picker, Nils, Mueller, Sabrina, Geier, Silke, Foersch, Johannes, Aberle, Jens, Martin, Stephan, Riedl, Matthias, Gabler, Maximilian
Publicado 2019

The DIVE/DPV registries: evolution of empagliflozin use in clinical practice in Germany

por Bramlage, Peter, Tittel, Sascha R, Wagner, Christian, König, Kerstin, Raddatz, Dirk, Weber-Lauffer, Rosmarie, Erath, Diether, Hilgenberg, Jost, Spies, Carsten, Danne, Thomas, Gabler, Maximilian, Foersch, Johannes, Ley, Ludwin, Seufert, Jochen
Publicado 2020

Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRat...

por Vistisen, Dorte, Carstensen, Bendix, Elisabetta, Patorno, Lanzinger, Stefanie, Tan, Elise Chia-Hui, Yabe, Daisuke, Kim, Dae Jung, Sheu, Wayne H.-H., Melzer-Cohen, Cheli, Holl, Reinhard W., Núñez, Júlio, Ha, Kyoung Hwa, Halvorsen, Sigrun, Langslet, Gisle, Karasik, Avraham, Nyström, Thomas, Niskanen, Leo, Guleria, Sonia, Klement, Riho, Carrasco, Marc, Foersch, Johannes, Shay, Christina, Koeneman, Lisette, Hoti, Fabian, Farsani, Soulmaz Fazeli, Khunti, Kamlesh, Zaccardi, Francesco, Subramanian, Anuradhaa, Nirantharakumar, Krishnarajah
Publicado 2023